NO986218D0 - FremgangsmÕte til Õ bestemme nµrvµr av hjerneprotein S-100 - Google Patents

FremgangsmÕte til Õ bestemme nµrvµr av hjerneprotein S-100

Info

Publication number
NO986218D0
NO986218D0 NO986218A NO986218A NO986218D0 NO 986218 D0 NO986218 D0 NO 986218D0 NO 986218 A NO986218 A NO 986218A NO 986218 A NO986218 A NO 986218A NO 986218 D0 NO986218 D0 NO 986218D0
Authority
NO
Norway
Prior art keywords
determining
procedure
brain protein
brain
protein
Prior art date
Application number
NO986218A
Other languages
English (en)
Other versions
NO986218L (no
Inventor
Jan Brundell
Lena Nyberg
Original Assignee
Sangtec Medical Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sangtec Medical Ab filed Critical Sangtec Medical Ab
Publication of NO986218L publication Critical patent/NO986218L/no
Publication of NO986218D0 publication Critical patent/NO986218D0/no

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6893—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to diseases not provided for elsewhere
    • G01N33/6896—Neurological disorders, e.g. Alzheimer's disease
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/574—Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • G01N33/57407—Specifically defined cancers
    • G01N33/5743—Specifically defined cancers of skin, e.g. melanoma

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Immunology (AREA)
  • Biomedical Technology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Hematology (AREA)
  • Medicinal Chemistry (AREA)
  • Urology & Nephrology (AREA)
  • Organic Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Physics & Mathematics (AREA)
  • Biophysics (AREA)
  • Microbiology (AREA)
  • Analytical Chemistry (AREA)
  • Cell Biology (AREA)
  • Biotechnology (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Oncology (AREA)
  • Food Science & Technology (AREA)
  • Genetics & Genomics (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Hospice & Palliative Care (AREA)
  • Toxicology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Peptides Or Proteins (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
NO986218A 1996-07-05 1998-12-30 FremgangsmÕte til Õ bestemme nµrvµr av hjerneprotein S-100 NO986218D0 (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
SE9602677A SE9602677D0 (sv) 1996-07-05 1996-07-05 Methods for determining brain antigens
PCT/SE1997/001164 WO1998001471A1 (en) 1996-07-05 1997-06-27 Methods for determining the presence of brain protein s-100

Publications (2)

Publication Number Publication Date
NO986218L NO986218L (no) 1998-12-30
NO986218D0 true NO986218D0 (no) 1998-12-30

Family

ID=20403304

Family Applications (1)

Application Number Title Priority Date Filing Date
NO986218A NO986218D0 (no) 1996-07-05 1998-12-30 FremgangsmÕte til Õ bestemme nµrvµr av hjerneprotein S-100

Country Status (13)

Country Link
EP (1) EP0931094B1 (no)
JP (1) JP2000515854A (no)
AT (1) ATE301671T1 (no)
AU (1) AU715797B2 (no)
BR (1) BR9710175A (no)
CA (1) CA2259413A1 (no)
DE (1) DE69733957T2 (no)
ES (1) ES2247633T3 (no)
IL (1) IL127278A0 (no)
NO (1) NO986218D0 (no)
NZ (1) NZ333408A (no)
SE (1) SE9602677D0 (no)
WO (1) WO1998001471A1 (no)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6555327B1 (en) * 1998-08-28 2003-04-29 Canag Diagnostics Ab Monoclonal antibodies against S100
ATE447713T1 (de) * 1998-11-05 2009-11-15 Univ Michigan S100-proteine und -autoantikörper als serummarker für krebs
CA2263063C (en) 1999-02-26 2004-08-10 Skye Pharmatech Incorporated Method for diagnosing and distinguishing stroke and diagnostic devices for use therein
US6780606B1 (en) 1999-02-26 2004-08-24 Synx Pharma, Inc. Method for diagnosing and distinguishing stroke and diagnostic devices for use therein
EP1216417A1 (de) * 1999-09-28 2002-06-26 Evotec OAI AG Quantitative analyse und typisierung subzellulärer partikel
AU2001265714A1 (en) * 2000-06-14 2001-12-24 Universite Libre De Bruxelles Marker for neurodegenerative diseases and its use for drug screening targeted against said diseases
ES2394331B2 (es) * 2011-06-17 2013-07-15 Universidade De Santiago De Compostela Uso de un péptido antigénico aislado derivado de la proteína s100-beta no unido a una molécula mhc de clase ii en la prevención, tratamiento, diagnóstico y/o seguimiento de la diabetes tipo i
ES2394972B2 (es) * 2011-06-17 2013-07-19 Universidade De Santiago De Compostela Péptido antigénico aislado derivado de la proteína s100-beta, procedimiento de identificación y su uso en la prevención, tratamiento, diagnóstico y/o seguimiento de la diabetes tipo i.
CN102331502B (zh) * 2011-08-31 2013-12-04 内蒙古科慧生物科技有限责任公司 人s100蛋白(s-100)定量测定试剂盒
WO2014194329A1 (en) * 2013-05-31 2014-12-04 Banyan Biomarkers, Inc. NEURAL SPECIFIC S100β FOR BIOMARKER ASSAYS AND DEVICES FOR DETECTION OF A NEUROLOGICAL CONDITION
CN111487409A (zh) * 2019-01-28 2020-08-04 艾维可生物科技有限公司 一种s100b蛋白的化学发光法检测试剂盒及其使用方法

Also Published As

Publication number Publication date
NZ333408A (en) 1999-05-28
EP0931094B1 (en) 2005-08-10
ES2247633T3 (es) 2006-03-01
AU3563397A (en) 1998-02-02
BR9710175A (pt) 2000-01-11
AU715797B2 (en) 2000-02-10
WO1998001471A1 (en) 1998-01-15
SE9602677D0 (sv) 1996-07-05
CA2259413A1 (en) 1998-01-15
IL127278A0 (en) 1999-09-22
EP0931094A1 (en) 1999-07-28
DE69733957T2 (de) 2006-04-13
NO986218L (no) 1998-12-30
DE69733957D1 (de) 2005-09-15
JP2000515854A (ja) 2000-11-28
ATE301671T1 (de) 2005-08-15

Similar Documents

Publication Publication Date Title
DK532284A (da) Fremgangsmaade til bestemmelse af antigenaktive aminosyresekvenser
Hoffman Allergens in bee venom: III. Identification of allergen B of bee venom as an acid phosphatase
WO2001084140A3 (de) Verfahren und vorrichtung zur qualitativen und/oder quantitativen bestimmung eines protein- und/oder peptidmusters einer flüssigkeitsprobe, die dem menschlichen oder tierischen körper entnommen wird
ATE209356T1 (de) Ein verfahren zur bestimmung von kollagenfragmenten in körperflüssigkeiten, ein testkit und mittel zur durchführung des verfahrens, und seine verwendung zur feststellung von mit dem kollagenmetabolismus assoziierten störungen
NO986218L (no) FremgangsmÕte til Õ bestemme nµrvµr av hjerneprotein S-100
KR970700772A (ko) T 세포 항원 수용체의 v 영역 단백질 및 그것의 제조 방법(t cell antigen receptor v region proteins and methods of preparation thereof)
GR3018371T3 (en) Method for identifying or determining proteins and applications therefor.
PT100978A (pt) Peptidos recombitopos, sequencias de acidos nucleicos que os codificam, composicoes terapeuticas que os contem e seu uso
ES2080047T3 (es) Peptidos hiv y metodos para la deteccion de hiv.
HK1021229A1 (en) A in vitro method of determining the presence of aprotein in an isolated biological sample.
BRPI0406265A (pt) Método para análise eletroforética capilar, métodos para pesquisa e tipagem de proteìnas monoclonais, processo para preparação de anticorpos modificados, anticorpos modificados, kit para detecção e tipagem de proteìnas monoclonais e uso de anticorpos
DE3787706D1 (de) Verfahren zur quantitativen Bestimmung der Antigene und Antikörper.
BR9713450A (pt) Quimiocinas de mamìfero
SE9002212D0 (sv) Igg binding protein
ATE124706T1 (de) Verfahren zur isolierung von basalmembranproteinen aus menschlichen und tierischen geweben.
NO172084C (no) Monoklonalt antistoff, anvendelse derav samt reagenssystem for immunologisk bestemmelse av fritt protein s og c4bp-protein s kompleks
FR2722508B1 (fr) Cassette d'expression d'une proteine p30 de toxoplasma gondii
Lloyd et al. The antigenic constituents of cattle skin washings
DE3855007D1 (de) METHODE ZUR REINIGUNG REKOMBINANTER t-PA VON DEN IHREN ENTSPRECHENDEN WIRTSZELLPROTEINEN
ES2136534A1 (es) Uso de la cd-1 sacalina para la deteccion y seguimiento de la enfermedad celiaca.
Xu Separation and characterization of sperm antigens using two-dimensional gel electrophoresis and immunoblotting
ATE75050T1 (de) Reagenzsatz, seine verwendung und diagnostisches verfahren zur bestimmung von humanen pankreasspezifischen proteinen.
MX9602274A (es) Procedimiento para la preservacion de antigenos sin usar inhibidores enzimaticos y su aplicacion en metodos inmunologicos.
HUT60039A (en) Method for detecting allergy to food proteins and screening test set applicable for said method
ATE85087T1 (de) Verfahren zur bestimmung von plasma-protein und testsatz dafuer.

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application